ArticleEuropean journal of case reports in internal medicine2025
Sudden Bilateral Vision Loss in A Young Patient with Systemic Autoimmune Disease and A Normal Brain MRI, which Responded to Steroid Treatment.
Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sudden bilateral visual loss is a rare but alarming manifestation, particularly in young patients with systemic autoimmune disorders. Case report: We describe the case of a 26-year-old woman with systemic lupus erythematosus, juvenile idiopathic arthritis, and Sjögren's syndrome, who presented with sudden bilateral vision loss following headache, vomiting, and diarrhoea. Ophthalmologic evaluation excluded hydroxychloroquine toxicity. Brain magnetic resonance imaging revealed no acute ischemic or demyelinating lesions. High-dose intravenous methylprednisolone was initiated, leading to near-complete recovery of vision. Conclusion: Autoimmune optic neuropathy should be considered in young patients with sudden bilateral vision loss, even in the absence of neuroimaging abnormalities. Prompt recognition and empirical corticosteroid therapy may prevent irreversible disability. LEARNING POINTS: Sudden bilateral vision loss in young patients with autoimmune diseases should raise suspicion for immune-mediated optic neuropathy.Normal magnetic resonance imaging and fundoscopy findings do not exclude serious inflammatory pathology.Early empirical corticosteroid therapy can be vision-saving.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.